Takeda to present phase 3 cancer drug data at ESMO 2026

September 22, 2026 9:30 AM

Takeda Pharmaceutical (TSE: 4502 / NYSE: TAK) will present new oncology pipeline data at the European Society for Medical Oncology ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found